{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:51:45Z","timestamp":1792651905608,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-021-00264-y","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T12:03:25Z","timestamp":1636632205000},"page":"1204-1223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia"],"prefix":"10.1038","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1435-3475","authenticated-orcid":false,"given":"Claudie","family":"Bosc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Saland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Bousard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Gadaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5427-8110","authenticated-orcid":false,"given":"Guillaume","family":"Cognet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Farge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Boet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Gotan\u00e8gre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Aroua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7832-9146","authenticated-orcid":false,"given":"Pierre-Luc","family":"Mouchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Polley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Larrue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00e9onore","family":"Kaphan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrine","family":"Sahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latifa","family":"Jarrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5278-5952","authenticated-orcid":false,"given":"Marie","family":"Tosolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Rambow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Cabon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Nicot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Poillet-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3051-8022","authenticated-orcid":false,"given":"Quentin","family":"Fovez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Kluza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9785-3883","authenticated-orcid":false,"given":"Rafael Jos\u00e9","family":"Arg\u00fcello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Mazzotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Avet-Loiseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Vergez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Tamburini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Fourni\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7417-4343","authenticated-orcid":false,"given":"Ing S.","family":"Tiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7514-3298","authenticated-orcid":false,"given":"Andrew H.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Kaoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Marine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3332-4525","authenticated-orcid":false,"given":"Christian","family":"R\u00e9cher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-981X","authenticated-orcid":false,"given":"Lucille","family":"Stuani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7551-356X","authenticated-orcid":false,"given":"Carine","family":"Joffre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-2032","authenticated-orcid":false,"given":"Jean-Emmanuel","family":"Sarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"264_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature22993","volume":"547","author":"LI Shlush","year":"2017","unstructured":"Shlush, L. I. et al. Tracing the origins of relapse in acute myeloid leukaemia to stem cells. Nature 547, 104\u2013108 (2017).","journal-title":"Nature"},{"key":"264_CR2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","volume":"10","author":"NJ Short","year":"2020","unstructured":"Short, N. J. et al. Advances in the treatment of acute myeloid leukemia: new drugs and new challenges. Cancer Discov. 10, 506\u2013525 (2020).","journal-title":"Cancer Discov."},{"key":"264_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41586-018-0251-7","volume":"559","author":"AM Intlekofer","year":"2018","unstructured":"Intlekofer, A. M. et al. Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations. Nature 559, 125\u2013129 (2018).","journal-title":"Nature"},{"key":"264_CR4","doi-asserted-by":"publisher","unstructured":"McMahon, C. M. et al. Clonal selection with RAS pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-1453 (2019).","DOI":"10.1158\/2159-8290.CD-18-1453"},{"key":"264_CR5","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge, T. et al. Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Discov. 7, 716\u2013735 (2017).","journal-title":"Cancer Discov."},{"key":"264_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.leukres.2017.09.021","volume":"62","author":"K Henkenius","year":"2017","unstructured":"Henkenius, K. et al. Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia. Leuk. Res. 62, 56\u201363 (2017).","journal-title":"Leuk. Res."},{"key":"264_CR7","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/nm.4399","volume":"23","author":"EM Kuntz","year":"2017","unstructured":"Kuntz, E. M. et al. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. Nat. Med. 23, 1234\u20131240 (2017).","journal-title":"Nat. Med."},{"key":"264_CR8","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nature13611","volume":"514","author":"A Viale","year":"2014","unstructured":"Viale, A. et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 514, 628\u2013632 (2014).","journal-title":"Nature"},{"key":"264_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cmet.2017.10.013","volume":"26","author":"C Bosc","year":"2017","unstructured":"Bosc, C., Selak, M. A. & Sarry, J.-E. Resistance is futile: targeting mitochondrial energetics and metabolism to overcome drug resistance in cancer treatment. Cell Metab. 26, 705\u2013707 (2017).","journal-title":"Cell Metab."},{"key":"264_CR10","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.cmet.2017.09.006","volume":"26","author":"S Andrzejewski","year":"2017","unstructured":"Andrzejewski, S. et al. PGC-1\u03b1 promotes breast cancer metastasis and confers bioenergetic flexibility against metabolic drugs. Cell Metab. 26, e5 (2017).","journal-title":"Cell Metab."},{"key":"264_CR11","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.cmet.2017.09.009","volume":"26","author":"K Lee","year":"2017","unstructured":"Lee, K. et al. MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation. Cell Metab. 26, e7 (2017).","journal-title":"Cell Metab."},{"key":"264_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1172\/JCI38942","volume":"120","author":"I Samudio","year":"2010","unstructured":"Samudio, I. et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J. Clin. Invest. 120, 142\u2013156 (2010).","journal-title":"J. Clin. Invest."},{"key":"264_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s41241-017-0022-z","volume":"37","author":"SE S\u00e1nchez-Mendoza","year":"2017","unstructured":"S\u00e1nchez-Mendoza, S. E. & Rego, E. M. Targeting the mitochondria in acute myeloid leukemia. Appl. Cancer Res. 37, 22 (2017).","journal-title":"Appl. Cancer Res."},{"key":"264_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou, E. D. et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 12, 329\u2013341 (2013).","journal-title":"Cell Stem Cell"},{"key":"264_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1158\/2159-8290.CD-13-0609","volume":"4","author":"R Pan","year":"2014","unstructured":"Pan, R. et al. Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia. Cancer Discov. 4, 362\u2013375 (2014).","journal-title":"Cancer Discov."},{"key":"264_CR16","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","volume":"6","author":"M Konopleva","year":"2016","unstructured":"Konopleva, M. et al. Efficacy and biological correlates of response in a phase ii study of venetoclax monotherapy in patients with acute myelogenous leukemia. Cancer Discov. 6, 1106\u20131117 (2016).","journal-title":"Cancer Discov."},{"key":"264_CR17","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1182\/blood.2019003988","volume":"135","author":"CD DiNardo","year":"2020","unstructured":"DiNardo, C. D. et al. Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML. Blood 135, 791\u2013803 (2020).","journal-title":"Blood"},{"key":"264_CR18","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina, J. R. et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat. Med. 24, 1036\u20131046 (2018).","journal-title":"Nat. Med."},{"key":"264_CR19","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.ccell.2018.08.007","volume":"34","author":"AL Boyd","year":"2018","unstructured":"Boyd, A. L. et al. Identification of chemotherapy-induced leukemic-regenerating cells reveals a transient vulnerability of human AML recurrence. Cancer Cell 34, e5 (2018).","journal-title":"Cancer Cell"},{"key":"264_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2012.08.038","volume":"151","author":"T-T Vo","year":"2012","unstructured":"Vo, T.-T. et al. Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML. Cell 151, 344\u2013355 (2012).","journal-title":"Cell"},{"key":"264_CR21","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.1206727","volume":"334","author":"TN Chonghaile","year":"2011","unstructured":"Chonghaile, T. N. et al. Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science 334, 1129\u20131133 (2011).","journal-title":"Science"},{"key":"264_CR22","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1158\/0008-5472.CAN-19-0515","volume":"79","author":"M Hosseini","year":"2019","unstructured":"Hosseini, M. et al. Targeting myeloperoxidase disrupts mitochondrial redox balance and overcomes cytarabine resistance in human acute myeloid leukemia. Cancer Res. 79, 5191\u20135203 (2019).","journal-title":"Cancer Res."},{"key":"264_CR23","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.yjmcc.2009.02.021","volume":"46","author":"AP Halestrap","year":"2009","unstructured":"Halestrap, A. P. What is the mitochondrial permeability transition pore? J. Mol. Cell. Cardiol. 46, 821\u2013831 (2009).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"264_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ceca.2011.04.007","volume":"50","author":"A Rasola","year":"2011","unstructured":"Rasola, A. & Bernardi, P. Mitochondrial permeability transition in Ca2+-dependent apoptosis and necrosis. Cell Calcium 50, 222\u2013233 (2011).","journal-title":"Cell Calcium"},{"key":"264_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60177-1","volume":"10","author":"B Wacquier","year":"2020","unstructured":"Wacquier, B., Combettes, L. & Dupont, G. Dual dynamics of mitochondrial permeability transition pore opening. Sci. Rep. 10, 3924 (2020).","journal-title":"Sci. Rep."},{"key":"264_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fonc.2018.00333","volume":"8","author":"G Cannino","year":"2018","unstructured":"Cannino, G., Ciscato, F., Masgras, I., S\u00e1nchez-Mart\u00edn, C. & Rasola, A. Metabolic plasticity of tumor cell mitochondria. Front. Oncol. 8, 333 (2018).","journal-title":"Front. Oncol."},{"key":"264_CR27","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.bbabio.2009.01.019","volume":"1787","author":"EJ Griffiths","year":"2009","unstructured":"Griffiths, E. J. & Rutter, G. A. Mitochondrial calcium as a key regulator of mitochondrial ATP production in mammalian cells. Biochim. Biophys. Acta Bioenergy 1787, 1324\u20131333 (2009).","journal-title":"Biochim. Biophys. Acta Bioenergy"},{"key":"264_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17882-2","volume":"11","author":"C Bosc","year":"2020","unstructured":"Bosc, C. et al. Autophagy regulates fatty acid availability for oxidative phosphorylation through mitochondria-endoplasmic reticulum contact sites. Nat. Commun. 11, 4056 (2020).","journal-title":"Nat. Commun."},{"key":"264_CR29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner, J. W. et al. Functional genomic landscape of acute myeloid leukaemia. Nature 562, 526\u2013531 (2018).","journal-title":"Nature"},{"key":"264_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1182\/blood.2019898114","volume":"134","author":"CL Jones","year":"2019","unstructured":"Jones, C. L. et al. Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II. Blood 134, 389\u2013394 (2019).","journal-title":"Blood"},{"key":"264_CR31","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1182\/blood.2019001580","volume":"134","author":"L Stuani","year":"2019","unstructured":"Stuani, L. & Sarry, J.-E. Help from outside: cysteine to survive in AML. Blood 134, 336\u2013338 (2019).","journal-title":"Blood"},{"key":"264_CR32","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","volume":"24","author":"DA Pollyea","year":"2018","unstructured":"Pollyea, D. A. et al. Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Nat. Med. 24, 1859\u20131866 (2018).","journal-title":"Nat. Med."},{"key":"264_CR33","doi-asserted-by":"publisher","first-page":"26046","DOI":"10.18632\/oncotarget.25433","volume":"9","author":"F Lucantoni","year":"2018","unstructured":"Lucantoni, F., D\u00fcssmann, H., Llorente-Folch, I. & Prehn, J. H. M. BCL2 and BCL(X)L selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2-deoxy-D-glucose. Oncotarget 9, 26046\u201326063 (2018).","journal-title":"Oncotarget"},{"key":"264_CR34","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.ccell.2019.08.005","volume":"36","author":"R Gui\u00e8ze","year":"2019","unstructured":"Gui\u00e8ze, R. et al. Mitochondrial reprogramming underlies resistance to BCL-2 inhibition in lymphoid malignancies. Cancer Cell 36, e13 (2019).","journal-title":"Cancer Cell"},{"key":"264_CR35","doi-asserted-by":"publisher","first-page":"eaax2863","DOI":"10.1126\/scitranslmed.aax2863","volume":"11","author":"D Sharon","year":"2019","unstructured":"Sharon, D. et al. Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response. Sci. Transl. Med. 11, eaax2863 (2019).","journal-title":"Sci. Transl. Med."},{"key":"264_CR36","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones, C. L. et al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell 34, e4 (2018).","journal-title":"Cancer Cell"},{"key":"264_CR37","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","volume":"10","author":"S Pei","year":"2020","unstructured":"Pei, S. et al. Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia. Cancer Discov. 10, 536\u2013551 (2020).","journal-title":"Cancer Discov."},{"key":"264_CR38","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/s43018-020-0103-x","volume":"1","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia. Nat. Cancer 1, 826\u2013839 (2020).","journal-title":"Nat. Cancer"},{"key":"264_CR39","doi-asserted-by":"publisher","unstructured":"Stevens, B. M. et al. Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells. Nat. Cancer https:\/\/doi.org\/10.1038\/s43018-020-00126-z (2020).","DOI":"10.1038\/s43018-020-00126-z"},{"key":"264_CR40","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1158\/2159-8290.CD-18-0140","volume":"8","author":"HE Ramsey","year":"2018","unstructured":"Ramsey, H. E. et al. A novel MCL1 inhibitor combined with venetoclax rescues venetoclax-resistant acute myelogenous leukemia. Cancer Discov. 8, 1566\u20131581 (2018).","journal-title":"Cancer Discov."},{"key":"264_CR41","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ccr.2006.10.006","volume":"10","author":"M Konopleva","year":"2006","unstructured":"Konopleva, M. et al. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell 10, 375\u2013388 (2006).","journal-title":"Cancer Cell"},{"key":"264_CR42","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"264_CR43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tcb.2015.10.002","volume":"26","author":"MG Daniel","year":"2016","unstructured":"Daniel, M. G., Pereira, C.-F., Lemischka, I. R. & Moore, K. A. Making a hematopoietic stem cell. Trends Cell Biol. 26, 202\u2013214 (2016).","journal-title":"Trends Cell Biol."},{"key":"264_CR44","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1093\/nar\/gks281","volume":"40","author":"EH Bresnick","year":"2012","unstructured":"Bresnick, E. H., Katsumura, K. R., Lee, H.-Y., Johnson, K. D. & Perkins, A. S. Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies. Nucleic Acids Res. 40, 5819\u20135831 (2012).","journal-title":"Nucleic Acids Res."},{"key":"264_CR45","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1080\/15548627.2019.1586256","volume":"15","author":"L Fernandez-Mosquera","year":"2019","unstructured":"Fernandez-Mosquera, L. et al. Mitochondrial respiratory chain deficiency inhibits lysosomal hydrolysis. Autophagy 15, 1572\u20131591 (2019).","journal-title":"Autophagy"},{"key":"264_CR46","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/pcmr.12704","volume":"31","author":"F Abbate","year":"2018","unstructured":"Abbate, F. et al. FBXW7 regulates a mitochondrial transcription program by modulating MITF. Pigment Cell Melanoma Res. 31, 636\u2013640 (2018).","journal-title":"Pigment Cell Melanoma Res."},{"key":"264_CR47","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.celrep.2020.01.022","volume":"30","author":"B Shin","year":"2020","unstructured":"Shin, B. et al. Mitochondrial oxidative phosphorylation regulates the fate decision between pathogenic Th17 and regulatory T cells. Cell Rep. 30, 1898\u20131909 (2020).","journal-title":"Cell Rep."},{"key":"264_CR48","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-019-1821-z","volume":"576","author":"J Wei","year":"2019","unstructured":"Wei, J. et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature 576, 471\u2013476 (2019).","journal-title":"Nature"},{"key":"264_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fonc.2017.00075","volume":"7","author":"T Vervliet","year":"2017","unstructured":"Vervliet, T. et al. Modulation of Ca2+\u2009signaling by anti-apoptotic B-cell lymphoma 2 proteins at the endoplasmic reticulum\u2013mitochondrial interface. Front. Oncol. 7, 75 (2017).","journal-title":"Front. Oncol."},{"key":"264_CR50","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bbabio.2017.01.003","volume":"1858","author":"A Danese","year":"2017","unstructured":"Danese, A. et al. Calcium regulates cell death in cancer: roles of the mitochondria and mitochondria-associated membranes (MAMs). Biochim. Biophys. Acta Bioenergy 1858, 615\u2013627 (2017).","journal-title":"Biochim. Biophys. Acta Bioenergy"},{"key":"264_CR51","first-page":"180","volume":"1835","author":"H Akl","year":"2013","unstructured":"Akl, H. & Bultynck, G. Altered Ca(2+) signaling in cancer cells: proto-oncogenes and tumor suppressors targeting IP3 receptors. Biochim. Biophys. Acta 1835, 180\u2013193 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"264_CR52","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.bbamcr.2013.01.021","volume":"1833","author":"B Bonneau","year":"2013","unstructured":"Bonneau, B., Prudent, J., Popgeorgiev, N. & Gillet, G. Non-apoptotic roles of Bcl-2 family: the calcium connection. Biochim. Biophys. Acta Mol. Cell Res. 1833, 1755\u20131765 (2013).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"264_CR53","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.bbabio.2009.01.005","volume":"1787","author":"RM Denton","year":"2009","unstructured":"Denton, R. M. Regulation of mitochondrial dehydrogenases by calcium ions. Biochim. Biophys. Acta Bioenerg. 1787, 1309\u20131316 (2009).","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"264_CR54","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1054\/ceca.2000.0168","volume":"28","author":"TE Gunter","year":"2000","unstructured":"Gunter, T. E., Buntinas, L., Sparagna, G., Eliseev, R. & Gunter, K. Mitochondrial calcium transport: mechanisms and functions. Cell Calcium 28, 285\u2013296 (2000).","journal-title":"Cell Calcium"},{"key":"264_CR55","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","volume":"281","author":"DR Green","year":"1998","unstructured":"Green, D. R. & Reed, J. C. Mitochondria and apoptosis. Science 281, 1309\u20131312 (1998).","journal-title":"Science"},{"key":"264_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41375-019-0485-x","volume":"34","author":"R Bisaillon","year":"2020","unstructured":"Bisaillon, R. et al. Genetic characterization of ABT-199 sensitivity in human AML. Leukemia 34, 63\u201374 (2020).","journal-title":"Leukemia"},{"key":"264_CR57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13045-021-01076-4","volume":"14","author":"R Buettner","year":"2021","unstructured":"Buettner, R. et al. Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine. J. Hematol. Oncol. 14, 70 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"264_CR58","doi-asserted-by":"publisher","first-page":"894","DOI":"10.3324\/haematol.2020.252569","volume":"106","author":"A Maiti","year":"2020","unstructured":"Maiti, A. et al. Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens. Haematologica 106, 894\u2013898 (2020).","journal-title":"Haematologica"},{"key":"264_CR59","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.ccell.2017.11.003","volume":"32","author":"R Pan","year":"2017","unstructured":"Pan, R. et al. Synthetic lethality of combined Bcl-2 Inhibition and p53 activation in AML: mechanisms and superior antileukemic efficacy. Cancer Cell 32, e6 (2017).","journal-title":"Cancer Cell"},{"key":"264_CR60","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/2159-8290.CD-19-0510","volume":"9","author":"MR Savona","year":"2019","unstructured":"Savona, M. R. & Rathmell, J. C. Mitochondrial homeostasis in AML and gasping for response in resistance to BCL2 blockade. Cancer Discov. 9, 831\u2013833 (2019).","journal-title":"Cancer Discov."},{"key":"264_CR61","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/2159-8290.CD-19-0117","volume":"9","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment. Cancer Discov. 9, 890\u2013909 (2019).","journal-title":"Cancer Discov."},{"key":"264_CR62","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1158\/2159-8290.CD-19-0125","volume":"9","author":"T Nechiporuk","year":"2019","unstructured":"Nechiporuk, T. et al. The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells. Cancer Discov. 9, 910\u2013925 (2019).","journal-title":"Cancer Discov."},{"key":"264_CR63","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.cmet.2019.01.011","volume":"29","author":"KH Lin","year":"2019","unstructured":"Lin, K. H. et al. Systematic dissection of the metabolic-apoptotic interface in AML reveals heme biosynthesis to be a regulator of drug sensitivity. Cell Metab. 29, e7 (2019).","journal-title":"Cell Metab."},{"key":"264_CR64","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.cell.2018.06.025","volume":"174","author":"F Rambow","year":"2018","unstructured":"Rambow, F. et al. Toward minimal residual disease-directed therapy in melanoma. Cell 174, e19 (2018).","journal-title":"Cell"},{"key":"264_CR65","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.molmet.2019.10.002","volume":"33","author":"M Lacroix","year":"2020","unstructured":"Lacroix, M., Riscal, R., Arena, G., Linares, L. K. & Le Cam, L. Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer. Mol. Metab. 33, 2\u201322 (2020).","journal-title":"Mol. Metab."},{"key":"264_CR66","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","volume":"23","author":"R Haq","year":"2013","unstructured":"Haq, R. et al. Oncogenic BRAF regulates oxidative metabolism via PGC1\u03b1 and MITF. Cancer Cell 23, 302\u2013315 (2013).","journal-title":"Cancer Cell"},{"key":"264_CR67","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.canlet.2018.11.018","volume":"442","author":"C Brummer","year":"2019","unstructured":"Brummer, C. et al. Metabolic targeting synergizes with MAPK inhibition and delays drug resistance in melanoma. Cancer Lett. 442, 453\u2013463 (2019).","journal-title":"Cancer Lett."},{"key":"264_CR68","doi-asserted-by":"publisher","first-page":"8452","DOI":"10.18632\/oncotarget.2320","volume":"5","author":"EM Kim","year":"2014","unstructured":"Kim, E. M. et al. Nuclear and cytoplasmic p53 suppress cell invasion by inhibiting respiratory complex-I activity via Bcl-2 family proteins. Oncotarget 5, 8452\u20138465 (2014).","journal-title":"Oncotarget"},{"key":"264_CR69","doi-asserted-by":"publisher","first-page":"1250256","DOI":"10.1126\/science.1250256","volume":"345","author":"DR Green","year":"2014","unstructured":"Green, D. R., Galluzzi, L. & Kroemer, G. Metabolic control of cell death. Science 345, 1250256 (2014).","journal-title":"Science"},{"key":"264_CR70","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/j.ccell.2019.06.003","volume":"36","author":"I Baccelli","year":"2019","unstructured":"Baccelli, I. et al. Mubritinib targets the electron transport chain complex i and reveals the landscape of OXPHOS dependency in acute myeloid leukemia. Cancer Cell 36, e8 (2019).","journal-title":"Cancer Cell"},{"key":"264_CR71","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1038\/bcj.2015.19","volume":"5","author":"E Saland","year":"2015","unstructured":"Saland, E. et al. A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia. Blood Cancer J. 5, e297 (2015).","journal-title":"Blood Cancer J."},{"key":"264_CR72","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0006-3495(99)77239-5","volume":"76","author":"V Petronilli","year":"1999","unstructured":"Petronilli, V. et al. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys. J. 76, 725\u2013734 (1999).","journal-title":"Biophys. J."},{"key":"264_CR73","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1128\/MCB.01204-14","volume":"35","author":"M Tosolini","year":"2015","unstructured":"Tosolini, M. et al. Human monocyte recognition of adenosine-based cyclic dinucleotides unveils the A2a G\u03b1s protein-coupled receptor tonic inhibition of mitochondrially induced cell death. Mol. Cell. Biol. 35, 479\u2013495 (2015).","journal-title":"Mol. Cell. Biol."},{"key":"264_CR74","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.cmet.2020.11.007","volume":"32","author":"RJ Arg\u00fcello","year":"2020","unstructured":"Arg\u00fcello, R. J. et al. SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution. Cell Metab. 32, e7 (2020).","journal-title":"Cell Metab."},{"key":"264_CR75","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gky310","volume":"46","author":"J Chong","year":"2018","unstructured":"Chong, J. et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 46, W486\u2013W494 (2018).","journal-title":"Nucleic Acids Res."},{"key":"264_CR76","first-page":"e9","volume":"158","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. HNF4 regulates fatty acid oxidation and is required for renewal of intestinal stem cells in mice. Gastroenterology 158, e9 (2020).","journal-title":"Gastroenterology"},{"key":"264_CR77","doi-asserted-by":"publisher","first-page":"9818","DOI":"10.1021\/ac1021166","volume":"82","author":"E Melamud","year":"2010","unstructured":"Melamud, E., Vastag, L. & Rabinowitz, J. D. Metabolomic analysis and visualization engine for LC-MS data. Anal. Chem. 82, 9818\u20139826 (2010).","journal-title":"Anal. Chem."},{"key":"264_CR78","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1021\/acs.analchem.7b00396","volume":"89","author":"X Su","year":"2017","unstructured":"Su, X., Lu, W. & Rabinowitz, J. D. Metabolite spectral accuracy on orbitraps. Anal. Chem. 89, 5940\u20135948 (2017).","journal-title":"Anal. Chem."},{"key":"264_CR79","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nprot.2012.058","volume":"7","author":"M Spinazzi","year":"2012","unstructured":"Spinazzi, M., Casarin, A., Pertegato, V., Salviati, L. & Angelini, C. Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nat. Protoc. 7, 1235\u20131246 (2012).","journal-title":"Nat. Protoc."},{"key":"264_CR80","doi-asserted-by":"publisher","first-page":"7189","DOI":"10.1074\/jbc.M116.774471","volume":"292","author":"SA Mookerjee","year":"2017","unstructured":"Mookerjee, S. A., Gerencser, A. A., Nicholls, D. G. & Brand, M. D. Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements. J. Biol. Chem. 292, 7189\u20137207 (2017).","journal-title":"J. Biol. Chem."},{"key":"264_CR81","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"T-C Chou","year":"2010","unstructured":"Chou, T.-C. Drug combination studies and their synergy quantification using the Chou\u2013Talalay method. Cancer Res. 70, 440\u2013446 (2010).","journal-title":"Cancer Res."},{"key":"264_CR82","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/bioinformatics\/btq431","volume":"26","author":"BS Carvalho","year":"2010","unstructured":"Carvalho, B. S. & Irizarry, R. A. A framework for oligonucleotide microarray preprocessing. Bioinformatics 26, 2363\u20132367 (2010).","journal-title":"Bioinformatics"},{"key":"264_CR83","unstructured":"MacDonald, J. W. hugene20sttranscriptcluster.db: affymetrix hugene20 annotation data (chip hugene20sttranscriptcluster). R package version 8.7.0. (2017)."},{"key":"264_CR84","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1093\/bioinformatics\/btl476","volume":"22","author":"F Hong","year":"2006","unstructured":"Hong, F. et al. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics. 22, 2825\u20132827 (2006).","journal-title":"Bioinformatics."},{"key":"264_CR85","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1078\/0065-1281-00601","volume":"103","author":"CJF Van Noorden","year":"2001","unstructured":"Van Noorden, C. J. F. The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition. Acta Histochem. 103, 241\u2013251 (2001).","journal-title":"Acta Histochem."},{"key":"264_CR86","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"264_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).","journal-title":"Genome Biol."},{"key":"264_CR88","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gkz601","volume":"47","author":"F Pont","year":"2019","unstructured":"Pont, F., Tosolini, M. & Fourni\u00e9, J. J. Single-cell signature explorer for comprehensive visualization of single cell signatures across scRNA-seq datasets. Nucleic Acids Res. 47, e133 (2019).","journal-title":"Nucleic Acids Res."},{"key":"264_CR89","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/bioinformatics\/btz700","volume":"36","author":"A Federico","year":"2020","unstructured":"Federico, A. & Monti, S. hypeR: an R package for geneset enrichment workflows. Bioinformatics 36, 1307\u20131308 (2020).","journal-title":"Bioinformatics"}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00264-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:19:07Z","timestamp":1670084347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-021-00264-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":89,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["264"],"URL":"https:\/\/doi.org\/10.1038\/s43018-021-00264-y","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"assertion":[{"value":"9 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}